Thursday, May 07, 2015

Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications

Nanoscale, 2015, 7,8689-8694
DOI: 10.1039/C5NR00251F, Communication
Wanji Seo, Alexandr A. Kapralov, Galina V. Shurin, Michael R. Shurin, Valerian E. Kagan, Alexander Star
Nanotube carrier protects Doxorubicin from oxidative degradation in the tumor microenvironment enriched by myeloid regulatory cells expressing myeloperoxidase and peroxynitrite.
The content of this RSS Feed (c) The Royal Society of Chemistry


Click for full article

No comments:

Post a Comment